Albuminuria and its correlates in an Iranian type 2 diabetic population

Lipids in Health and Disease

Volumn 7, Issue , 2008, Pages

  Nakhjavani, Manouchehr ^a   Esteghamati, Alireza ^a   Esfahanian, Fatemeh ^a   Aghamohammadzadeh, Naser ^b   Hamidi, Sepehr ^a   Meysamie, Alipasha ^a   Abbasi, Mehrshad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; APOLIPOPROTEIN B; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRAN; KIDNEY DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; POPULATION RESEARCH; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION; ALBUMINURIA; HEALTH; MIDDLE AGED; SEXUAL DEVELOPMENT;

ALBUMINURIA; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH; HUMANS; IRAN; MALE; MIDDLE AGED; SEX CHARACTERISTICS;

EID: 50849128496     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-7-28     Document Type: Article

References (31)

1. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. S Wild G Roglic A Green R Sicree H King, Diabetes Care 2004 27 1047 1053 10.2337/diacare.27.5.1047 15111519
2. The Burden of Mortality Attributable to Diabetes. G Roglic N Unwin PH Bennett C Mathers J Tuomilehto S Nag V Connolly H King, Diabetes Care 2005 28 9 2130 5 10.2337/diacare.28.9.2130 16123478
3. Global burden of diabetes, 1995-2025. H King RE Aubert WH Herman, Diabetes Care 1998 21 1414 1431 10.2337/diacare.21.9.1414 9727886
4. Albumin excretion in diabetic patients in the setting of acute myocardial infarction: association with 3-year mortality. G Berton R Cordiano R Palmieri R De Toni GL Guarnieri P Palatini, Diabetologia 2004 47 1511 1518 10.1007/s00125-004-1486-4 15322753
5. Microalbuminuria as predictor of increased mortality in elderly people. EM Damsgaard A Froland OD Jorgensen CE Mogensen, Br Med J 1990 300 297 300 2106959
6. Glomerular structural changes and structural-functional relationships at early stage of diabetic nephropathy in Japanese type 2 diabetic patients. T Moriya K Tanaka R Moriya, Med Electron Microsc 2000 33 115 22 10.1007/s007950000010 11810468
7. Diabetes and cardiovascular disease. The Framingham study. WB Kannel DL McGee, JAMA 1979 241 2035 2038 10.1001/jama.241.19.2035 430798
8. Prevalence of Diabetes Mellitus and Impaired Fasting Glucose in the Adult Population of Iran: The National Survey of Risk Factors for Non-Communicable Diseases of Iran. A Esteghamati MM Gouya M Abbasi A Delavari S Alikhani F Alaedini A Safaie M Forouzanfar EW Gregg, Diabetes Care 2007 Oct 5; 17921357
9. Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome. A Estegamati M Abbasi M Nakhjaani A Yousefizadeh AP Basa H Afshar, Cardiovascular Diabetology 2006 5 15 16842631 10.1186/1475-2840-5-15
10. Diagnosis and classification of diabetes mellitus. American Diabetes Association, Diabetes Care 2005 28 S37 S42 10.2337/diacare.28.suppl_1.S37 15618111
11. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. World Health Organization, Report of a WHO consultation Geneva: World Health Organization 1999
12. the National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. AV Chobanian GL Bakris HR Black WC Cushman LA Green JL Izzo DW Jones BJ Materson S Oparil JT Wright EJ Roccella, JAMA 2003 289 19 2560 72 10.1001/jama.289.19.2560 12748199
13. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inspect tion cohort study. P Hovind L Tarnow P Rossing BR Jensen Graae I Trop C Binder HH Parving, BMJ 2004 328 7448 1105 1109 10.1136/bmj.38070.450891.FE 15096438
14. Nephropathy in patients in type 2 diabetes. G Remuzzi A Schieppati P Ruggenenti, N Engl J Med 2002 346 15 1145 52 10.1056/NEJMcp011773 11948275
15. Significance of Microalbuminuria in Long-Duration Type 1 Diabetes. CS Arun J Stoddart P Mackin JM MacLeod JP New SM Marshall, Diabetes Care 2003 26 2144 2149 10.2337/diacare.26.7.2144 12832327
16. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. MA Gall P Hougaard K Borch-Johnsen HH Parving, BMJ 1997 314 7083 783 788 9080995
17. Cardiovascular Risk Factors Are Differently Associated with Urinary Albumin Excretion in Men and Women. JC Verhave LH Hillege JGM Burgerhof G Navis D de Zeeuw PE de Jong, J Am Soc Nephrol 2003 14 1330 1335 10.1097/01.ASN. 0000060573.77611.73 12707402
18. Gender- and race-specific determination of albumin excretion rate using albumin-to-creatinine ratio in single, untimed urine specimens: The Coronary Artery Risk Development in Young Adults Study. DR Jacobs Jr MA Murtaugh M Steffes X Yu J Roseman FC Goetz, Am J Epidemiol 2002 155 1114 1119 10.1093/aje/155.12.1114 12048225
19. Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM. A Schmitz M Væth CE Mogensen, Diabetologia 1994 37 1251 8 10.1007/BF00399799 7895955
20. Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM. RG Nelson WC Knowler DJ Pettitt RL Hanson PH Bennett, Diabetes Care 1995 18 182 7 10.2337/diacare.18.2.182 7729295
21. Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey. CA Jones ME Francis MS Eberhardt B Chavers J Coresh M Engelgau JW Kusek D Byrd-Holt KM Narayan WH Herman CP Jones M Salive LY Agodoa, Am J Kidney Dis 2002 39 445 459 10.1053/ajkd.2002.31388 11877563
22. Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women. JC Verhave HL Hillege JG Burgerhof G Navis D de Zeeuw PE de Jong PREVEND Study Group, J Am Soc Nephrol 2003 14 5 1330 5 10.1097/01.ASN.0000060573.77611.73 12707402
23. Higher Levels of HDL Cholesterol Are Associated With a Decreased Likelihood of Albuminuria in Patients With Long-Standing Type 1 Diabetes. ME Molitch Demetra Rupp M Carnethon, Diabetes Care 2006 29 1 78 82 10.2337/diacare.29.01.06.dc05-1583 16373900
24. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. JS Yudkin RD Forrest CA Jackson, Lancet 1988 2 530 533 10.1016/S0140-6736(88)92657-8 2900920
25. Urinary albumin excretion. An independent predictor of ischemic heart disease. K Borch-Johnsen B Feldt-Rasmussen S Strandgaard M Schroll JS Jensen, Arterioscler Thromb Vasc Biol 1999 19 1992 1997 10446083
26. Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes. T Hiraga T Kobayashi M Okubo K Nakanishi T Sugimoto Y Ohashi T Murase, Diabetes Care 1995 18 241 244 10.2337/diacare.18.2.241 7729305
27. Lipoprotein(a) as a risk factor for cardiovascular mortality in type 2. diabetic patients: a 10-year follow-up study. C Hernandez G Francisco P Chacon R Simo, Diabetes Care 2005 28 4 931 3 10.2337/diacare.28.4.931 15793200
28. Effect of lipid reduction on the progression of renal disease: a meta-analysis. LF Fried TJ Orchard BL Kasiske, Kidney Int 2001 59 260 269 10.1046/j.1523-1755.2001.00487.x 11135079
29. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. R Collins J Armitage S Parish P Sleigh R Peto, Lancet 2003 361 2005 2016 10.1016/S0140-6736(03)12475-0 12814710
30. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. JF Moorhead M El-Nahas MK Chan Z Varghese, Lancet 1982 2 8311 1309 11 10.1016/S0140-6736(82)91513-6 6128601
31. Association of yslipidemia and Effects of Statins on Nonmacrovascular Diseases. SB Baghdasarian H Jneid BJ Hoogwerf, Clin Ther 2004 26 3 337 351 10.1016/S0149-2918(04)90031-8 15110128